Evidence map›Paper›PMID 41148630›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Determinants of Diagnosis Delay in a Sample of Breast Cancer Patients from the Mohammed VI Centre for Cancer Treatment.

Sbabou Mohammed, Bendahhou Karima, Errahmani Mohamed-Yassir, Mouafik Abdelilah, Tabiti Hajar, Tahiri Jouti Nadia

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sbabou MohammedLaboratory of Cellular and Molecular Inflammatory, Degenerative, and Oncologic Pathophysiology Faculty of Medicine and Pharmacy, Casablanca Hassan II University, Morocco.
Bendahhou KarimaDepartment of Epidemiology and Public Health, Ibn Rochd Hospital, Casablanca Cancer Registry, Casablanca, Morocco.
Errahmani Mohamed-YassirDesbrest Institute of Epidemiology and Public Health, INSERM, University of Montpelier, Montpellier, France.
Mouafik AbdelilahLaboratory of Engineering and Applied Technologies, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni Mellal, Morocco.
Tabiti HajarLaboratory of Cellular and Molecular Inflammatory, Degenerative, and Oncologic Pathophysiology Faculty of Medicine and Pharmacy, Casablanca Hassan II University, Morocco.ORCID 0009-0001-9205-940X
Tahiri Jouti NadiaLaboratory of Cellular and Molecular Inflammatory, Degenerative, and Oncologic Pathophysiology Faculty of Medicine and Pharmacy, Casablanca Hassan II University, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer (BC) is the most common type of cancer in women; a delayed diagnosis of BC is associated with advanced stages at diagnosis and reduced survival rates. This study aims to identify the barriers and factors contributing to delayed BC diagnosis among Moroccan women admitted to the Mohammed VI Oncology Center in Casablanca.

methodsWe conducted a cross-sectional study from January 2023 to July 2024 at the Mohammed VI Oncology Center in Casablanca. A questionnaire was administered to collect sociodemographic, clinical, behavioral, and healthcare system data. Stages I and IIa were classified as "early diagnosis," while stages IIb and above were classified as "delayed diagnosis." We used the Chi-square test to examine the association between independent variables and outcomes. All variables were included in a multiple logistic regression model using the stepwise backward method, and those with a p < 0.05 were retained in the final model.

resultA total of 436 patients were interviewed, and the majority had been diagnosed at a late stage (65.1%). The main factors and barriers included individuals residing in rural or semi-urban areas (OR=2.24, 95% CI [1.22-4.11]), opting for traditional treatments (OR=3.41, 95% CI [1.44-8.04]); individuals expressed a willingness to consult a doctor but faced barriers such as lack of time, financial constraints, or fear (OR=2.23, 95% CI [0.98-5.07]), and poor communication quality among administrative staff (OR = 7.48, 95% CI [1.06-52.68]). Conversely, having a family history of BC (OR=0.52, 95% CI [0.28-0.97]), knowledge about free-of-charge diagnostic services (OR=0.53, 95% CI [0.29-0.97]), and a positive behavior of the practitioner during the initial consultation (OR = 0.21, 95% CI [0.05-0.9]) emerged as protective factors against delayed presentation and diagnosis.

conclusionEfforts should concentrate on improving access to affordable, high-quality healthcare and increasing cancer awareness among the population and health professionals.

Indexed as

Breast NeoplasmsDelayed DiagnosisEarly Detection of CancerHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityAdultAgedCross-Sectional StudiesFemaleFollow-Up StudiesHumansMiddle AgedMoroccoPrognosisSurveys and Questionnairesbreast cancerdelayed diagnosisDeterminantMorocco

Identifiers

PMID41148630
PMCPMC12907453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.